Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer
Condition(s):Metastatic Colorectal CancerLast Updated:November 16, 2016Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Colorectal CancerLast Updated:November 16, 2016Terminated
Condition(s):Metastatic Colorectal CancerLast Updated:January 22, 2021Completed
Condition(s):Metastatic Colorectal CancerLast Updated:January 5, 2016Completed
Condition(s):Unresectable Metastatic Colorectal CancerLast Updated:July 15, 2021Not yet recruiting
Condition(s):Metastatic Colorectal CancerLast Updated:October 20, 2021Terminated
Condition(s):Metastatic Colorectal Cancer; BRAF V600E Mutation PositiveLast Updated:November 8, 2023Recruiting
Condition(s):Metastatic Colorectal CancerLast Updated:September 26, 2014Terminated
Condition(s):Metastatic Colorectal CancerLast Updated:September 21, 2011Completed
Condition(s):Metastatic Colorectal CancerLast Updated:August 8, 2018Completed
Condition(s):Metastatic Colorectal CancerLast Updated:December 5, 2011Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.